| No | 1 | Date of announcement | 2021/03/26 | Time of announcement | 18:21:40 |
|---|---|---|---|---|---|
| Subject | Oneness Biotech Co., LTD receives a European patent on OB318, a new drug in development for liver cancer. | ||||
| To which item it meets |
paragraph 53 | Date of events | 2021/03/26 | ||
| Statement | |||||
|
1.Date of occurrence of the event:2021/03/26
2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:OB318 has been granted a European patent titled ”COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF”under patent number EP 3240772 B1. 6.Countermeasures:None 7.Any other matters that need to be specified:OB318 has obtained patents titled ”COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF” in the U.S., Taiwan and Malaysia. |
|||||
